Furthermore, ITGB8 expression significantly decreased in GSCs pretreated with P38 inhibitor (Fig. 2L), and this was further confirmed by immunohistochemistry (IHC) staining in GBM samples (Fig. 2M). Here, ITGB8 is linked to glioblastoma.